Stockreport

Alvotech and STADA add to strategic alliance through denosumab partnership

Alvotech  (ALVO) 
PDF STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights [Read more]